(NASDAQ: MASI) Masimo's forecast annual revenue growth rate of 7.82% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.05%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.37%.
Masimo's revenue in 2026 is $1,526,900,000.On average, 12 Wall Street analysts forecast MASI's revenue for 2026 to be $86,535,228,004, with the lowest MASI revenue forecast at $82,620,787,654, and the highest MASI revenue forecast at $89,353,625,056. On average, 11 Wall Street analysts forecast MASI's revenue for 2027 to be $93,111,487,792, with the lowest MASI revenue forecast at $88,414,159,372, and the highest MASI revenue forecast at $96,556,195,300.
In 2028, MASI is forecast to generate $100,000,902,808 in revenue, with the lowest revenue forecast at $94,625,071,394 and the highest revenue forecast at $104,541,653,614.